__NUXT_JSONP__("/drugs/Dacetuzumab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"880486-59-9",chebiId:b,chemicalFormula:b,definition:"A humanized monoclonal antibody directed against the CD40 receptor with potential antineoplastic activity. Dacetuzumab specifically binds to and inhibits the CD40 receptor, thereby inducing apoptosis and inhibiting cellular proliferation via antibody-dependent cellular cytotoxicity (ADCC) in cells that overexpress this receptor. The CD40 receptor, a member of the tumor necrosis factor (TNF) receptor super-family, is highly expressed on most B lineage hematologic malignancies including multiple myeloma, non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Hodgkin's disease and acute lymphoblastic leukemia.",fdaUniiCode:"UT59FF4T5X",identifier:"C62179",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129822","C20401"],synonyms:["Anti-huCD40 mAb","DACETUZUMAB",a,"Monoclonal Antibody SGN-40","SGN-40","huS2C6"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FDacetuzumab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Dacetuzumab","","2021-10-30T13:42:01.983Z")));